Lower Cancer Drug Prices: Are Patients Really Paying Less?
The Hindu asks whether lower maximum retail prices (MRPs) on cancer drugs are actually making treatment cheaper for patients. It looks at whether those lower price tags turn into affordable care in practice.
Context
MRP is the maximum retail price printed on a product, so a cut there does not automatically lower what a patient pays at a pharmacy. Cancer drugs are often expensive, and India's medicine prices are overseen by the National Pharmaceutical Pricing Authority.
Burning Potato score: 62%